A Decade of Innovation: MBC BioLabs Celebrates Its 10-Year Anniversary

Ten years ago, with nothing but a modest warehouse and a vision to empower entrepreneurial scientists, we launched MBC BioLabs. Little did we know, that space would become the cradle of unprecedented success for our resident entrepreneurs. As silver balloons reflected our milestone '10', we gathered to celebrate a decade of extraordinary achievements. Together, MBC companies have initiated 153 clinical trials, introduced 71 products to market, and raised nearly $14 billion.

Over 350 friends joined us to toast to the indomitable spirit of these innovators who've transformed MBC BioLabs from humble beginnings to a powerhouse of biotech breakthroughs. The air was alive with stories of persistence, ingenuity, and triumph, reinforcing the essence of our mission: to serve the bright minds whose ideas blossom into life-changing solutions.

As the party wound down, the gratitude we felt was as towering as our bright orange anniversary cake. Each handshake, each shared memory, each new connection made was a reaffirmation of our commitment to supporting the next wave of biotech pioneers.

To all who have been part of this remarkable journey, thank you. Here's to a future where we continue to enable awesome, break barriers and hopefully celebrate many more decades of innovation.
ANNOUNCEMENTS

Residents Can Now Access CDD Vault for Chemical and Biological Data Organization

We are proud to start the year off announcing a new partnership with Collaborative Drug Discovery, Inc. This partnership provides our residents with five or fewer employees free access to the CDD Vault: a comprehensive scientific data management platform that enables researchers to intuitively organize and analyze both biological and chemical data, and to collaborate with partners through a secure web interface.

► MORE ON CDD

Astellas Future Innovator Prize Winners

After a competitive pitch process with over 25 applicants, TippingPoint Biosciences and Altay Therapeutics were recognized by Astellas executives for strength of the innovation in their approach, the therapeutic potential of their research, and the breadth of applicability of their technological platforms. Congratulations to both teams!

► READ MORE
NEWS FROM OUR COMMUNITY

Integrated Biosciences Announces Nature Publication Identifying New Class of Antibiotics Discovered Via Company’s AI-Powered Platform


► READ MORE

Tim Schnabel, CEO of Switch Bioworks Shares Insights On Sustainable Food Growth


► READ MORE

Nature Reviews Commentary on TAPIR, VCreate's T-Cell Receptor and Language Model


► READ MORE
UPCOMING EVENTS

Founders at Work: Maria Soloveychik and Charly Chahwan, Synthex Labs

 

January 25 @ 4pm - 5:30pm
953 Indiana St, San Francisco

We are excited to resume our Founders at Work Series! Don't miss the upcoming session featuring Maria and Charly from Synthex, and learn about their fascinating journey and partnership with BMS.

► LEARN MORE

Life Science Vendor's Showcase

 

February 21 @ 10am - 2pm
135 Mississippi St, San Francisco

 

Are you an external vendor looking to connect with MBC BioLabs' residents? Join us for our Life Science Vendors' Showcase!

► LEARN MORE

Partner Office Hours

Looking to connect with Sartorius, Agilent, Revvity, or Thermo Fisher Scientific - and enjoy a free treat? Check times and locations on our Partner calendar.

► CHECK THE CALENDAR
NEW COMPANIES

DirectBio

DirectBio commercializes a CRISPR based technology to diagnose human disease. DirectBio’s innovation is an amplification-free CRISPR diagnostic, meaning errors leading to false positive results are minimized. DirectBio was spun out of a $10M research project from the Gladstone Institutes and University of California, Berkeley and joined the 135 Mississippi Street community in November 2023.

► LEARN MORE 

NeuroAge Therapeutics

NeuroAge Therapeutics is a longevity biotech startup creating personalized drugs to reverse brain aging and treat dementia. NeuroAge plans to generate early revenue and data through its NeuroAge Test, a diagnostic for brain aging that is currently available in beta on their website. The NeuroAge team hails from MIT, Cambridge, and UC Berkeley, and has come through the Stanford Longevity competition, the National Institute on Aging Startup Challenge, and Berkeley SkyDeck. NeuroAge joined the 135 Mississippi Street community in September of 2023.

► LEARN MORE

Iaterion, Inc.

Iaterion, Inc. plans to become the leading company in women’s health. The company is developing selective nuclear receptor modulators based on a platform discovered by its founders, and aims to create safe therapies for multiple indications driven by hormonal, immune or cell metabolism pathologies, including oncology. Iaterion also recently joined our 135 Mississippi Street community.

► LEARN MORE
SPECIAL THANKS TO OUR PARTNERS
MBC BioLabs - Enabling Awesome